Cargando…
Photosensitizer and peptide-conjugated PAMAM dendrimer for targeted in vivo photodynamic therapy
Challenges in photodynamic therapy (PDT) include development of efficient near infrared-sensitive photosensitizers (5,10,15,20-tetrakis(4-hydroxyphenyl)-21H,23H-porphine [PS]) and targeted delivery of PS to the tumor tissue. In this study, a dual functional dendrimer was synthesized for targeted PDT...
Autores principales: | Narsireddy, Amreddy, Vijayashree, Kurra, Adimoolam, Mahesh G, Manorama, Sunkara V, Rao, Nalam M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639554/ https://www.ncbi.nlm.nih.gov/pubmed/26604753 http://dx.doi.org/10.2147/IJN.S89474 |
Ejemplares similares
-
DNA Condensation by Peptide-Conjugated PAMAM Dendrimers.
Influence of Peptide Charge
por: Dannert, Corinna, et al.
Publicado: (2023) -
Polyethylene glycolated PAMAM dendrimers-Efavirenz conjugates
por: Pyreddy, Suneela, et al.
Publicado: (2014) -
In Vitro Evaluation of Third Generation PAMAM Dendrimer Conjugates
por: Najlah, Mohammad, et al.
Publicado: (2017) -
Twenty Years of Research on Cyclodextrin Conjugates with PAMAM Dendrimers
por: Arima, Hidetoshi
Publicado: (2021) -
An Evaluation of CXCR4 Targeting with PAMAM Dendrimer Conjugates for Oncologic Applications
por: Lesniak, Wojciech G., et al.
Publicado: (2022)